Terms: = Pancreatic cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Treatment
5 results:
1. Glutamine synthetase and hepatocellular carcinoma.
Jiang J; Hu Y; Fang D; Luo J
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
[TBL] [Abstract] [Full Text] [Related]
2. IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.
Pang N; Shi J; Qin L; Chen A; Tang Y; Yang H; Huang Y; Wu Q; Li X; He B; Li T; Liang B; Zhang J; Cao B; Liu M; Feng Y; Ye X; Chen X; Wang L; Tian Y; Li H; Li J; Hu H; He J; Hu Y; Zhi C; Tang Z; Gong Y; Xu F; Xu L; Fan W; Zhao M; Chen D; Lian H; Yang L; Li P; Zhang Z
J Hematol Oncol; 2021 Jul; 14(1):118. PubMed ID: 34325726
[TBL] [Abstract] [Full Text] [Related]
3. Co-expression of IL-7 and PH20 promote anti-gpc3 CAR-T tumour suppressor activity in vivo and in vitro.
Xiong X; Xi J; Liu Q; Wang C; Jiang Z; Yue SY; Shi L; Rong Y
Liver Int; 2021 May; 41(5):1033-1043. PubMed ID: 33347692
[TBL] [Abstract] [Full Text] [Related]
4. Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment.
Ma W; Zhu D; Li J; Chen X; Xie W; Jiang X; Wu L; Wang G; Xiao Y; Liu Z; Wang F; Li A; Shao D; Dong W; Liu W; Yuan Y
Theranostics; 2020; 10(3):1281-1295. PubMed ID: 31938065
[No Abstract] [Full Text] [Related]
5. [Evaluation of Quality Indicators of Evidence-Based Guidelines Using ADT/GEKID Base Dataset and its Organ-Specific Modules].
Gebauer A; Barlag H; Wesselmann S; Biedenweg L; Weitmann K; Klinkhammer-Schalke M; Hoffmann W
Gesundheitswesen; 2020 Sep; 82(8-09):710-715. PubMed ID: 31842241
[TBL] [Abstract] [Full Text] [Related]